Synthesis and biological evaluation of triazolyl-substituted benzyloxyacetohydroxamic acids as LpxC inhibitors. 2020

Katharina Hoff, and Sebastian Mielniczuk, and Oriana Agoglitta, and Maria Teresa Iorio, and Manlio Caldara, and Emre F Bülbül, and Jelena Melesina, and Wolfgang Sippl, and Ralph Holl
Institute of Organic Chemistry, University of Hamburg, Martin-Luther-King-Platz 6, 20146 Hamburg, Germany; German Center for Infection Research (DZIF), Partner Site Hamburg-Lübeck-Borstel-Riems.

The bacterial deacetylase LpxC is a promising target for the development of antibiotics selectively combating Gram-negative bacteria. To improve the biological activity of the reported benzyloxyacetohydroxamic acid 9 ((S)-N-hydroxy-2-{2-hydroxy-1-[4-(phenylethynyl)phenyl]ethoxy}acetamide), its hydroxy group was replaced by a triazole ring. Therefore, in divergent syntheses, triazole derivatives exhibiting rigid and flexible lipophilic side chains, different configurations at their stereocenter, and various substitution patterns at the triazole ring were synthesized, tested for antibacterial and LpxC inhibitory activity, and structure-activity relationships were deduced based on docking and binding energy calculations.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D006090 Gram-Negative Bacteria Bacteria which lose crystal violet stain but are stained pink when treated by Gram's method. Gram Negative Bacteria
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006877 Hydroxamic Acids A class of weak acids with the general formula R-CONHOH. Hydroxamic Acid,Acid, Hydroxamic,Acids, Hydroxamic
D000581 Amidohydrolases Any member of the class of enzymes that catalyze the cleavage of amide bonds and result in the addition of water to the resulting molecules. Amidases,Amidohydrolase
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001426 Bacterial Proteins Proteins found in any species of bacterium. Bacterial Gene Products,Bacterial Gene Proteins,Gene Products, Bacterial,Bacterial Gene Product,Bacterial Gene Protein,Bacterial Protein,Gene Product, Bacterial,Gene Protein, Bacterial,Gene Proteins, Bacterial,Protein, Bacterial,Proteins, Bacterial
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

Katharina Hoff, and Sebastian Mielniczuk, and Oriana Agoglitta, and Maria Teresa Iorio, and Manlio Caldara, and Emre F Bülbül, and Jelena Melesina, and Wolfgang Sippl, and Ralph Holl
February 2014, Bioorganic & medicinal chemistry,
Katharina Hoff, and Sebastian Mielniczuk, and Oriana Agoglitta, and Maria Teresa Iorio, and Manlio Caldara, and Emre F Bülbül, and Jelena Melesina, and Wolfgang Sippl, and Ralph Holl
March 2016, Bioorganic & medicinal chemistry,
Katharina Hoff, and Sebastian Mielniczuk, and Oriana Agoglitta, and Maria Teresa Iorio, and Manlio Caldara, and Emre F Bülbül, and Jelena Melesina, and Wolfgang Sippl, and Ralph Holl
September 2013, Organic & biomolecular chemistry,
Katharina Hoff, and Sebastian Mielniczuk, and Oriana Agoglitta, and Maria Teresa Iorio, and Manlio Caldara, and Emre F Bülbül, and Jelena Melesina, and Wolfgang Sippl, and Ralph Holl
December 2021, Bioorganic chemistry,
Katharina Hoff, and Sebastian Mielniczuk, and Oriana Agoglitta, and Maria Teresa Iorio, and Manlio Caldara, and Emre F Bülbül, and Jelena Melesina, and Wolfgang Sippl, and Ralph Holl
June 2016, ACS medicinal chemistry letters,
Katharina Hoff, and Sebastian Mielniczuk, and Oriana Agoglitta, and Maria Teresa Iorio, and Manlio Caldara, and Emre F Bülbül, and Jelena Melesina, and Wolfgang Sippl, and Ralph Holl
September 2013, Journal of medicinal chemistry,
Katharina Hoff, and Sebastian Mielniczuk, and Oriana Agoglitta, and Maria Teresa Iorio, and Manlio Caldara, and Emre F Bülbül, and Jelena Melesina, and Wolfgang Sippl, and Ralph Holl
March 2016, European journal of medicinal chemistry,
Katharina Hoff, and Sebastian Mielniczuk, and Oriana Agoglitta, and Maria Teresa Iorio, and Manlio Caldara, and Emre F Bülbül, and Jelena Melesina, and Wolfgang Sippl, and Ralph Holl
December 2010, Steroids,
Katharina Hoff, and Sebastian Mielniczuk, and Oriana Agoglitta, and Maria Teresa Iorio, and Manlio Caldara, and Emre F Bülbül, and Jelena Melesina, and Wolfgang Sippl, and Ralph Holl
February 2023, Bioorganic chemistry,
Katharina Hoff, and Sebastian Mielniczuk, and Oriana Agoglitta, and Maria Teresa Iorio, and Manlio Caldara, and Emre F Bülbül, and Jelena Melesina, and Wolfgang Sippl, and Ralph Holl
April 2013, Bioorganic & medicinal chemistry,
Copied contents to your clipboard!